# A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

> **NCT01193478** · PHASE1 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 71 (actual)

## Conditions studied

- HCV Infection

## Interventions

- **DRUG:** GS-5885
- **DRUG:** Placebo
- **DRUG:** GS-5885
- **DRUG:** Placebo
- **DRUG:** GS-5885
- **DRUG:** Placebo
- **DRUG:** GS-5885
- **DRUG:** Placebo
- **DRUG:** GS-5885
- **DRUG:** Placebo
- **DRUG:** GS-5885
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01193478
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-01
- **Final completion:** 2011-12
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2013-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01193478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01193478, "A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01193478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*